 |
|
|
|
Vetter Opens New Sales Office at Illinois
Science + Technology Park in Suburban Chicago
In keeping with its strategy
of U.S. growth and expansion, Vetter, a specialist in
aseptically prefilled drug-delivery systems, today
announced that it has opened a new sales office at the
Illinois Science +Technology Park in Skokie. The office
will be managed by Mr. Troy Carpenter, who was appointed
as President of Vetter Pharma International USA Inc. rvice – is scheduled
to be operational in the beginning of the fourth quarter
of 2010.
|
|
|
|
|
|
|
 |
Myconostica Announces CE Marking of MycAssay™ Product Family on
Additional Platforms
Myconostica Ltd,
the UK-based medical diagnostic company developing and
commercialising rapid and highly specific tests for
life-threatening fungal infections, today announces the
CE marking of its lead products
MycAssay™ Aspergillus
and
MycAssay™ Pneumocystis
on the Roche Lightcycler® 2.0 and Stratagene Mx3000
series platforms.
|
|
|
 |
       |
       |
       |
       |
       |
|
 
|
|
|
|
|
|
|
|
|
|
Other Non-European countries
|
|
|
|
|
|
   |
   |
|
|
 |
|
|
 |
|
31.08.2010 Health Canada Grants Full
Approval of Sativex For the Treatment of Spasticity
Due to Multiple Sclerosis |
GW Pharmaceuticals
(AIM: GWP)
and Bayer Inc.,
a subsidiary of Bayer AG,
today announced that Health Canada has approved Sativex®
[delta-9-tetrahydrocannabinol 27 mg/mL (from Tetrabinex®
- cannabis sativa L. extract) and cannabidiol 25 mg/mL
(from Nabidiolex® - cannabis sativa L. extract)] as
adjunctive treatment for symptomatic relief of
spasticity in adult patients with multiple sclerosis
(MS). Sativex® is the first cannabinoid medicine derived
from whole plant extracts from the cannabis sativa plant
containing both delta-9-tetrahydrocannabinol and
cannabidiol. This means that people in Canada with MS
experiencing the debilitating symptoms of spasticity,
such as painful spasms and cramps, will now have a new
treatment option in addition to standard therapy.
|
|
|
|
|
|
31.08.2010 Vetter Opens New Sales
Office at Illinois Science + Technology Park in Suburban
Chicago |
In keeping with its strategy
of U.S. growth and expansion, Vetter, a specialist in
aseptically prefilled drug-delivery systems, today
announced that it has opened a new sales office at the
Illinois Science +Technology Park in Skokie. The office
will be managed by Mr. Troy Carpenter, who was appointed
as President of Vetter Pharma International USA Inc. The
new office replaces its Yardley, Pennsylvania sales
office, founded in 1983 as Vetter Pharma-Turm Inc.
|
|
|
|
|
| |
|
|
|
|
|
| |
 |
| |
 |
| |
TAQXpedit PCR System (FAST End-Point) |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
  |
| |
  |
| |
  |
| |
  |
| |
  |
| |
  |
|
|
|
  |
| |
  |
| |
|
| |
|
| |
 |
| |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
All rights reserved